activins has been researched along with Cardiac Remodeling, Ventricular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alqallaf, A; Boateng, SY; Clavere, NG; Mitchell, R; Parnell, A; Patel, K; Rostron, KA | 1 |
| O'Meara, CC; Paddock, SJ | 1 |
| Hu, J; Huang, CX; Shan, YG; Tang, YH; Wang, X; Wang, ZQ; Zou, Q | 1 |
| Chen, WJ; de Roos, A; Diamant, M; Greulich, S; Lamb, HJ; Lammertsma, AA; Lubberink, M; Ouwens, DM; Rijzewijk, LJ; Romijn, JA; Ruige, JB; Smit, JW; van der Meer, RW | 1 |
| Liu, H; Liu, M; Liu, Z; Wei, Q; Yang, C; Yang, J; Yang, P | 1 |
| Ding, M; Li, SM; Liu, GH; Liu, M; Yang, CY; Yang, P; Zhang, WQ | 1 |
1 trial(s) available for activins and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.
Topics: Activins; Adipose Tissue; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Heart; Heart Ventricles; Humans; Hypoglycemic Agents; Inhibin-beta Subunits; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Myocardium; Myocytes, Cardiac; Organ Size; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome; Ventricular Remodeling | 2013 |
5 other study(ies) available for activins and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Inhibition of activin A receptor signalling attenuates age-related pathological cardiac remodelling.
Topics: Activins; Animals; Heart Diseases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Progeria; Ventricular Remodeling | 2022 |
Steps toward therapeutically targeting the activin type II receptor for treating heart failure.
Topics: Activin Receptors; Activins; Fibrosis; Heart Failure; Humans; Ventricular Remodeling | 2020 |
Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats.
Topics: Activins; Animals; Biomarkers; Cytokines; Disease Models, Animal; Follistatin; Heart Function Tests; Immunohistochemistry; Inflammation Mediators; Male; Myocardial Infarction; Myocardium; NF-kappa B; Rats; Sympathetic Nervous System; Ventricular Remodeling | 2018 |
Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure.
Topics: Activins; Animals; Biomarkers; Biopsy; Disease Models, Animal; Female; Fibrosis; Follistatin; Gene Expression Regulation; Heart Failure; Heart Function Tests; Heart Ventricles; Hemodynamics; Immunohistochemistry; Myocardial Infarction; Ramipril; Rats; Ventricular Remodeling | 2016 |
Lipopolysaccharide induced activin A-follistatin imbalance affects cardiac fibrosis.
Topics: Activins; Animals; Cell Proliferation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Follistatin; Immunohistochemistry; Lipopolysaccharides; Myocardium; Nitric Oxide; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Ventricular Remodeling | 2012 |